Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function

Dades bibliogràfiques
Autors principals: Hardman, C, Chen, W, Luo, J, Batty, P, Chen, Y, Nahler, J, Wu, Y, Pavord, I, Erpenbeck, V, Sandham, D, Xue, L, Ogg, G
Format: Journal article
Publicat: Elsevier 2019

Ítems similars